166 related articles for article (PubMed ID: 36931705)
1. Providing recurrence risk counselling for parents after diagnosis of a serious genetic condition caused by an apparently de novo mutation in their child: a qualitative investigation of the PREGCARE strategy with UK clinical genetics practitioners.
Kay AC; Wells J; Hallowell N; Goriely A
J Med Genet; 2023 Sep; 60(9):925-931. PubMed ID: 36931705
[TBL] [Abstract][Full Text] [Related]
2. Professionals' views on providing personalized recurrence risks for de novo mutations: Implications for genetic counseling.
Kay AC; Wells J; Goriely A; Hallowell N
J Genet Couns; 2024 Jun; ():. PubMed ID: 38924179
[TBL] [Abstract][Full Text] [Related]
3. Parental mosaicism for apparent de novo genetic variants: Scope, detection, and counseling challenges.
Zemet R; Van den Veyver IB; Stankiewicz P
Prenat Diagn; 2022 Jun; 42(7):811-821. PubMed ID: 35394072
[TBL] [Abstract][Full Text] [Related]
4. Personalized recurrence risk assessment following the birth of a child with a pathogenic de novo mutation.
Bernkopf M; Abdullah UB; Bush SJ; Wood KA; Ghaffari S; Giannoulatou E; Koelling N; Maher GJ; Thibaut LM; Williams J; Blair EM; Kelly FB; Bloss A; Burkitt-Wright E; Canham N; Deng AT; Dixit A; Eason J; Elmslie F; Gardham A; Hay E; Holder M; Homfray T; Hurst JA; Johnson D; Jones WD; Kini U; Kivuva E; Kumar A; Lees MM; Leitch HG; Morton JEV; Németh AH; Ramachandrappa S; Saunders K; Shears DJ; Side L; Splitt M; Stewart A; Stewart H; Suri M; Clouston P; Davies RW; Wilkie AOM; Goriely A
Nat Commun; 2023 Feb; 14(1):853. PubMed ID: 36792598
[TBL] [Abstract][Full Text] [Related]
5. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
[TBL] [Abstract][Full Text] [Related]
6. Parental mosaicism detection and preimplantation genetic testing in families with multiple transmissions of de novo mutations.
Xu N; Shi W; Cao X; Zhou X; Jin L; Huang HF; Chen S; Xu C
J Med Genet; 2023 Sep; 60(9):910-917. PubMed ID: 36707240
[TBL] [Abstract][Full Text] [Related]
7. De novo mtDNA point mutations are common and have a low recurrence risk.
Sallevelt SC; de Die-Smulders CE; Hendrickx AT; Hellebrekers DM; de Coo IF; Alston CL; Knowles C; Taylor RW; McFarland R; Smeets HJ
J Med Genet; 2017 Feb; 54(2):73-83. PubMed ID: 27450679
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcomes after assisted human reproduction.
Okun N; Sierra S; ;
J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
[TBL] [Abstract][Full Text] [Related]
9. A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.
Wadrup F; Holden S; MacLeod R; Miedzybrodzka Z; Németh AH; Owens S; Pasalodos S; Quarrell O; Clarke AJ;
Eur J Hum Genet; 2019 Aug; 27(8):1215-1224. PubMed ID: 30890781
[TBL] [Abstract][Full Text] [Related]
10. Multiple transmissions of de novo mutations in families.
Jónsson H; Sulem P; Arnadottir GA; Pálsson G; Eggertsson HP; Kristmundsdottir S; Zink F; Kehr B; Hjorleifsson KE; Jensson BÖ; Jonsdottir I; Marelsson SE; Gudjonsson SA; Gylfason A; Jonasdottir A; Jonasdottir A; Stacey SN; Magnusson OT; Thorsteinsdottir U; Masson G; Kong A; Halldorsson BV; Helgason A; Gudbjartsson DF; Stefansson K
Nat Genet; 2018 Dec; 50(12):1674-1680. PubMed ID: 30397338
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Mosaicism and prenatal diagnosis options: insights from retinoblastoma.
Dehainault C; Golmard L; Millot GA; Charpin A; Laugé A; Tarabeux J; Aerts I; Cassoux N; Stoppa-Lyonnet D; Gauthier-Villars M; Houdayer C
Eur J Hum Genet; 2017 Feb; 25(3):381-383. PubMed ID: 28000698
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prenatally diagnosed structural congenital anomalies.
Gagnon A;
J Obstet Gynaecol Can; 2009 Sep; 31(9):875-881. PubMed ID: 19941713
[TBL] [Abstract][Full Text] [Related]
14. From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.
Zhytnik L; Peters M; Tilk K; Simm K; Tõnisson N; Reimand T; Maasalu K; Acharya G; Krjutškov K; Salumets A
Hum Reprod Update; 2021 Oct; 27(6):1056-1085. PubMed ID: 34329448
[TBL] [Abstract][Full Text] [Related]
15. A novel approach using long-read sequencing and ddPCR to investigate gonadal mosaicism and estimate recurrence risk in two families with developmental disorders.
Wilbe M; Gudmundsson S; Johansson J; Ameur A; Stattin EL; Annerén G; Malmgren H; Frykholm C; Bondeson ML
Prenat Diagn; 2017 Nov; 37(11):1146-1154. PubMed ID: 28921562
[TBL] [Abstract][Full Text] [Related]
16. Confirming the contribution and genetic spectrum of de novo mutation in infantile spasms: Evidence from a Chinese cohort.
Liu L; Liu F; Wang Q; Xie H; Li Z; Lu Q; Wang Y; Zhang M; Zhang Y; Picker J; Cui X; Zou L; Chen X
Mol Genet Genomic Med; 2021 Jun; 9(6):e1689. PubMed ID: 33951346
[TBL] [Abstract][Full Text] [Related]
17. Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications.
Cook CB; Armstrong L; Boerkoel CF; Clarke LA; du Souich C; Demos MK; Gibson WT; Gill H; Lopez E; Patel MS; Selby K; Abu-Sharar Z; ; Elliott AM; Friedman JM
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34697084
[TBL] [Abstract][Full Text] [Related]
18. Germline mosaicism in Rett syndrome identified by prenatal diagnosis.
Mari F; Caselli R; Russo S; Cogliati F; Ariani F; Longo I; Bruttini M; Meloni I; Pescucci C; Schurfeld K; Toti P; Tassini M; Larizza L; Hayek G; Zappella M; Renieri A
Clin Genet; 2005 Mar; 67(3):258-60. PubMed ID: 15691364
[TBL] [Abstract][Full Text] [Related]
19. Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature.
Van Steijvoort E; Chokoshvili D; W Cannon J; Peeters H; Peeraer K; Matthijs G; Borry P
Hum Reprod Update; 2020 Apr; 26(3):335-355. PubMed ID: 32099997
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
